About Zealand Pharma
Zealand Pharma is a company based in Glostrup (Denmark) founded in 1998.. The company has 335 employees as of December 31, 2024. Zealand Pharma has completed 2 acquisitions, including Encycle Therapeutics and Valeritas. Zealand Pharma operates in a competitive market with competitors including Merck, Roivant Sciences, AbbVie, Gilead and Lilly, among others.
- Headquarter Glostrup, Denmark
- Employees 335 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Zealand Pharma A/S
-
Annual Revenue
$8.73 M (USD)-81.71as on Dec 31, 2024
-
Net Profit
$-150.45 M (USD)-53.3as on Dec 31, 2024
-
EBITDA
$-172.74 M (USD)-133.28as on Dec 31, 2024
-
Latest Funding Round
- Investors
-
Employee Count
335
as on Dec 31, 2024
-
Investments & Acquisitions
Encycle Therapeutics
& 1 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Zealand Pharma
Zealand Pharma is a publicly listed company on the OMXCOP with ticker symbol ZEAL in Denmark, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Unlock access to complete
Unlock access to complete
Leadership Team
36 people
Senior Team
26 people
Software Development Team
25 people
Board Team
6 people
Data Analysis and Operations Team
5 people
Finance and Accounting
4 people
Principal Team
4 people
Product Management Team
4 people
Unlock access to complete
Funding Insights of Zealand Pharma
- Total Funding Total Funding
- Total Rounds 5
- Last Round Last Round
-
First Round
First Round
(12 Dec 2014)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2024 | Amount | Post-IPO - Zealand Pharma | Valuation |
investors |
|
| Oct, 2022 | Amount | Post-IPO - Zealand Pharma | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Zealand Pharma | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Zealand Pharma
Zealand Pharma has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Athyrium Capital Management. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Global private equity investments are managed by the firm.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Zealand Pharma
Zealand Pharma has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Encycle Therapeutics and Valeritas. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Peptide mimetics to target protein-protein interactions to treat inflammatory bowel disease and fibrosis.
|
2012 | ||||
|
Wearable insulin patch pumps are developed for transdermal delivery.
|
2003 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Zealand Pharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Zealand Pharma Comparisons
Competitors of Zealand Pharma
Zealand Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Merck, Roivant Sciences, AbbVie, Gilead and Lilly, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Pharmaceutical products are manufactured and marketed worldwide.
|
|
| domain | founded_year | HQ Location |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed.
|
|
| domain | founded_year | HQ Location |
Biopharmaceutical research and drug development are conducted globally by AbbVie.
|
|
| domain | founded_year | HQ Location |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others
|
|
| domain | founded_year | HQ Location |
Traditional pharmaceutical medicines are developed for multiple health fields.
|
|
| domain | founded_year | HQ Location |
Developer of drugs for the treatment of multiple disorders
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Zealand Pharma
Frequently Asked Questions about Zealand Pharma
When was Zealand Pharma founded?
Zealand Pharma was founded in 1998 and raised its 1st funding round 16 years after it was founded.
Where is Zealand Pharma located?
Zealand Pharma is headquartered in Glostrup, Denmark.
Who is the current CEO of Zealand Pharma?
Adam Steensberg is the current CEO of Zealand Pharma.
How many employees does Zealand Pharma have?
As of Dec 31, 2024, the latest employee count at Zealand Pharma is 335.
What is the annual revenue of Zealand Pharma?
Annual revenue of Zealand Pharma is $8.73M as on Dec 31, 2024.
What does Zealand Pharma do?
Zealand Pharma was founded in 1998 and is headquartered in Glostrup, Denmark. Protein therapeutics for diabetes and gastrointestinal disorders are developed through a proprietary pipeline. Products are licensed to partners including Sanofi, Helsinn Healthcare, and Boehringer Ingelheim. Lixisenatide, a GLP-1 analog for type 2 diabetes, has been licensed to Sanofi. Ongoing programs include ZP4207 for severe hypoglycemia in Phase II and ZP1848 for short bowel syndrome in Phase II.
Who are the top competitors of Zealand Pharma?
Zealand Pharma's top competitors include Merck, Roivant Sciences and AbbVie.
Is Zealand Pharma publicly traded?
Yes, Zealand Pharma is publicly traded on OMXCOP under the ticker symbol ZEAL.
How many acquisitions has Zealand Pharma made?
Zealand Pharma has made 2 acquisitions, including Encycle Therapeutics, and Valeritas.
Who are Zealand Pharma's investors?
Zealand Pharma has 1 investor. Key investors include Athyrium Capital Management.
What is Zealand Pharma's ticker symbol?
The ticker symbol of Zealand Pharma is ZEAL on OMXCOP.